dx 9065a has been researched along with thromboplastin in 12 studies
Studies (dx 9065a) | Trials (dx 9065a) | Recent Studies (post-2010) (dx 9065a) | Studies (thromboplastin) | Trials (thromboplastin) | Recent Studies (post-2010) (thromboplastin) |
---|---|---|---|---|---|
92 | 7 | 8 | 10,540 | 281 | 2,126 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (41.67) | 18.2507 |
2000's | 7 (58.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoshima, K; Asakura, H; Ikeda, T; Jokaji, H; Kumabashiri, I; Matsuda, T; Morishita, E; Saito, M; Uotani, C; Yamazaki, M | 2 |
Hara, T; Ishihara, H; Iwamoto, M; Tanabe, K; Yokoyama, A | 1 |
Prasa, D; Stürzebecher, J; Svendsen, L | 1 |
Avril, C; Bono, F; Herault, JP; Herbert, JM; Schaeffer, P | 1 |
Carmeliet, P; de Prost, D; Herbert, JM; Melis, E; Ollivier, V | 1 |
Akahane, K; Higure, A; Itoh, H; Kikuchi, M; Kitahara, K; Ohsato, K; Ohuchida, T; Okamoto, K; Takeda, S; Todoroki, H | 1 |
Nagashima, H | 1 |
Alexander, J; Becker, RC; Dyke, CK; Harrington, RA | 1 |
Alexander, JH; Becker, RC; Harrington, RA; Kunitada, S; Li, Y; Robertson, T; Spencer, FA; Yang, H | 1 |
Furugohri, T; Honda, Y; Isobe, K; Matsumoto, C; Muramatsu, S; Shiozaki, Y; Sugiyama, N | 1 |
Graff, J; Harder, S; Picard-Willems, B | 1 |
1 review(s) available for dx 9065a and thromboplastin
Article | Year |
---|---|
Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease.
Topics: Animals; Anticoagulants; Area Under Curve; Blood Coagulation; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Artery Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Humans; International Normalized Ratio; Mice; Models, Biological; Models, Chemical; Naphthalenes; Pilot Projects; Platelet Aggregation Inhibitors; Propionates; Rats; Thrombin; Thromboplastin; Thrombosis; Time Factors | 2004 |
11 other study(ies) available for dx 9065a and thromboplastin
Article | Year |
---|---|
Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
Topics: Administration, Oral; Animals; Anticoagulants; Disseminated Intravascular Coagulation; Drug Evaluation, Preclinical; Endotoxins; Factor Xa Inhibitors; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Kidney Glomerulus; Male; Naphthalenes; Partial Thromboplastin Time; Platelet Count; Propionates; Prothrombin Time; Rats; Rats, Wistar; Thromboplastin | 1994 |
DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats.
Topics: Animals; Anticoagulants; Arteriovenous Shunt, Surgical; Bleeding Time; Blood Coagulation; Disseminated Intravascular Coagulation; Factor Xa Inhibitors; Fibrin Fibrinogen Degradation Products; Fibrinogen; Male; Naphthalenes; Platelet Count; Propionates; Rats; Rats, Wistar; Thromboplastin | 1995 |
Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats.
Topics: Administration, Oral; Animals; Anticoagulants; Disease Models, Animal; Disseminated Intravascular Coagulation; Factor X; Factor Xa Inhibitors; Male; Naphthalenes; Propionates; Rats; Rats, Wistar; Thromboplastin | 1996 |
Inhibition of thrombin generation in plasma by inhibitors of factor Xa.
Topics: Animals; Anticoagulants; Arginine; Arthropod Proteins; Cattle; Dipeptides; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Hirudins; Humans; Intercellular Signaling Peptides and Proteins; Kinetics; Molecular Structure; Naphthalenes; Partial Thromboplastin Time; Peptides; Pipecolic Acids; Piperidines; Propionates; Rabbits; Recombinant Proteins; Serine Proteinase Inhibitors; Sulfonamides; Sulfones; Thrombin; Thromboplastin | 1997 |
Activation of human vascular endothelial cells by factor Xa: effect of specific inhibitors.
Topics: Anticoagulants; Calcium; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Naphthalenes; Oligosaccharides; Phosphatidylinositols; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Propionates; Thromboplastin | 1999 |
Tissue factor is not involved in the mitogenic activity of factor VIIa.
Topics: Animals; Antithrombins; Cell Division; Cells, Cultured; Factor VIIa; Factor Xa Inhibitors; Fibroblasts; Hirudins; Mice; Mice, Transgenic; Mutation; Naphthalenes; Propionates; Thromboplastin | 2001 |
Inhibition of factor Xa suppresses the expression of tissue factor in human monocytes and lipopolysaccharide-induced endotoxemia in rats.
Topics: Animals; Chemokine CCL2; Endotoxemia; Factor Xa; Factor Xa Inhibitors; Humans; Immunohistochemistry; Lipopolysaccharides; Liver; Male; Monocytes; Naphthalenes; Propionates; Rats; Rats, Wistar; RNA, Messenger; Thromboplastin | 2001 |
Studies on the different modes of action of the anticoagulant protease inhibitors DX-9065a and Argatroban. II. Effects on fibrinolysis.
Topics: Anticoagulants; Arginine; Blood Coagulation; Fibrinolysis; Humans; Kinetics; Naphthalenes; Pipecolic Acids; Propionates; Sulfonamides; Thrombomodulin; Thromboplastin | 2002 |
Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitor.
Topics: Antithrombin III; Cells, Cultured; Endothelium, Vascular; Humans; Naphthalenes; Propionates; Signal Transduction; Thromboplastin | 2004 |
Different antithrombotic properties of factor Xa inhibitor and thrombin inhibitor in rat thrombosis models.
Topics: Animals; Azetidines; Benzylamines; Blood Coagulation; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Glycine; Male; Naphthalenes; Propionates; Rats; Rats, Wistar; Thrombin; Thromboplastin; Thrombosis | 2005 |
Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a.
Topics: Adult; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Daboia; Drug Monitoring; Enoxaparin; Factor Xa Inhibitors; Fondaparinux; Heparin; Humans; Naphthalenes; Partial Thromboplastin Time; Polysaccharides; Propionates; Thromboplastin; Viper Venoms | 2007 |